A constitutively activated erythropoietin receptor stimulates proliferation and contributes to transformation of multipotent, committed nonerythroid and erythroid progenitor cells.
- 1 April 1994
- journal article
- research article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 14 (4) , 2266-2277
- https://doi.org/10.1128/mcb.14.4.2266
Abstract
If the env gene of spleen focus-forming virus (SFFV) is replaced by a cDNA encoding a constitutively active form of the erythropoietin receptor, EPO-R(R129C), the resultant recombinant virus, SFFVcEPO-R, induces transient thrombocytosis and erythrocytosis in infected mice. Clonogenic progenitor cell assays of cells from the bone marrow and spleens of these infected mice suggest that EPO-R(R129C) can stimulate proliferation of committed megakaryocytic and erythroid progenitors as well as nonerythroid multipotent progenitors. From the spleens of SFFVcEPO-R-infected mice, eight multiphenotypic immortal cell lines were isolated and characterized. These included primitive erythroid, lymphoid, and monocytic cells. Some expressed proteins characteristic of more than one lineage. All cell lines resulting from SFFVcEPO-R infection contained a mutant form of the p53 gene. However, in contrast to infection by SFFV, activation of PU.1 gene expression, by retroviral integration, was not observed. One cell line had integrated a provirus upstream of the fli-1 gene, in a location typically seen in erythroleukemic cells generated by Friend murine leukemia virus infection. This event led to increased expression of fli-1 in this cell line. Thus, infection by SFFVcEPO-R can induce proliferation and lead to transformation of nonerythroid as well as very immature erythroid progenitor cells. The sites of proviral integration in clonal cell lines are distinct from those in SFFV-derived lines.Keywords
This publication has 53 references indexed in Scilit:
- JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietinCell, 1993
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992
- The p53 tumour suppressor geneNature, 1991
- Tumurigenesis by slow-transforming retroviruses—an updateBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1990
- RAG-1 and RAG-2, Adjacent Genes That Synergistically Activate V(D)J RecombinationScience, 1990
- The molecular control of cell division, differentiation commitment and maturation in haemopoietic cellsNature, 1989
- Multilineage hematopoietic disorders induced by transplantation of bone marrow cells expressing the v-fms oncogeneCell, 1987
- An attempt to produce “pre‐T” cell hybridomas and to identify their antigensEuropean Journal of Immunology, 1986
- The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF 1Cell, 1985
- Cellular site and mode of Fv-2 gene actionCell, 1985